Scott A. Jalowayski




  • JD, summa cum laude, New York Law School, 1998; Articles Editor, New York Law School Law Review
  • MBA, Monterey Institute of International Studies, 1995
  • BA, University of California, Los Angeles, 1991


  • Japan, Gaikokuho Jimu Bengoshi (New York), 2012
  • Hong Kong, Solicitor, 2011
  • New York, 1999
  • Chambers Asia: Asia’s Leading Lawyers for Business (2009-2015)
  • Chambers Global: The World’s Leading Lawyers for Business (2011, 2013-2015)
  • IFLR 1000: The Guide to the World’s Leading Financial Law Firms (2011)

Scott A. Jalowayski


View the Chinese version.

Scott has practiced in Asia since 2000. He is widely recognized as a leading private equity lawyer in the region and has advised on transactions in China, India, Southeast Asia and Japan. In addition to Scott's experience representing private equity funds, he also has deep experience in representing multinationals in cross-border M&A and Joint Venture transactions in a variety of industries including health care, chemicals, solar energy, natural resources, telecommunications, media, retail, and technology.


Greater China
  • Represented Goldman Sachs in its US$100 million convertible bond financing of a subsidiary of HKSE-listed GCL New Energy Holdings Limited, a leading developer and operator of renewable energy projects in the PRC.
  • Represented the buyer consortium consisting of TPG and the Chairman of NYSE-listed ShangPharma Corporation in ShangPharma’s 13e-3 going-private transaction valued at approximately US$180 million.
  • Represented TPG and its portfolio company, Nexeo Solutions LLC, in Nexeo's joint venture with the executives of Beijing Plaschem.
  • Represented Bain Capital in the US$489 million sale of Shanghai-based Feixiang Chemicals to Rhodia S.A.
  • Represented D. E. Shaw, as the majority exchangeable bondholders in connection with the US$3.4 billion consolidation of Jiangsu Zhongneng and HKSE-Iisted GCL-Poly Energy. This transaction was awarded Asian Legal Business China 2009 M&A Deal of the Year.
  • Represented Quanta Computer in its joint venture with The 3M Company to manufacture and market touch screen technology solutions.
India and Southeast Asia
  • Advised a leading private equity fund in its purchase of a stake in Metropolis Healthcare Limited, a Mumbai-based chain of pathology laboratories, from Dr. GSK Velu and affiliates.
  • Represented a global investment bank in a US$100 million financing of an Indian-based wind turbine power plant developer. The financing included an issuance of BSE-listed NCDs, offshore debt, and warrants.
  • Represented TPG and its portfolio company, TE Asia Healthcare, in its joint venture with TalkMed Group Limited, a Singapore listed company providing medical oncology and palliative care services, for the purpose of establishing the Hong Kong Integrated Oncology Centre.
  • Represented an alternative asset manager as a senior secured lender in connection with the financing of the leveraged buyout of CAMGSM, Cambodia’s largest mobile telecommunications service provider.
  • Represented a global multi-strategy investor in its sale of a 267-room Tokyo hotel.
  • Represented a global private equity fund in its potential acquisition of a Japanese self-storage business.
  • Represented a global private equity fund in its potential acquisition of a Japanese consumer products business out of bankruptcy.
  • Represented TPG in its joint venture with Fortress to purchase a portfolio of properties from Citi Principal.
  • Represented a hedge fund investor in the sale of an apartment complex in Japan.